Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
Use this INBX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INBX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INBX SEC filings page. Lician reads the product cache first so this HTML stays unique to Inhibrx Biosciences, Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full INBX income, balance, and cash tables.